Acute Pancreatitis Management: From Resuscitation to Intervention
Clinical Practice Update — Severity Prediction, Fluid Therapy, Nutrition, ERCP Timing, and Management of Necrotising Disease in Adults
This is an original clinical education article informed by current guidelines and evidence. See References below for source documents.
- Clinical Focus
- Diagnosis, severity classification, early resuscitation, nutritional support, role of ERCP, and management of local complications including pancreatic necrosis in adult acute pancreatitis
- Target Audience
- General surgeons, acute care surgery teams, gastroenterologists, intensivists, emergency physicians, surgical residents
- Setting
- Emergency departments, acute medical and surgical wards, intensive care units, interventional endoscopy and radiology suites
- Source Evidence
- •IAP/APA Evidence-Based Guidelines for the Management of Acute Pancreatitis (Pancreatology, 2013)
- •ACG Clinical Guideline: Management of Acute Pancreatitis (Am J Gastroenterol, 2013)
- •Revised Atlanta Classification of Acute Pancreatitis (Gut, 2013)
- •PONCHO Trial — Same-Admission vs Interval Cholecystectomy after Mild Gallstone Pancreatitis (Lancet, 2015)
- •WATERFALL Trial — Aggressive vs Moderate Fluid Resuscitation in Acute Pancreatitis (NEJM, 2022)
- •Dutch Pancreatitis Study Group — Step-Up Approach to Necrotising Pancreatitis (NEJM, 2010 & updates)
- •TENSION Trial — Endoscopic vs Surgical Step-Up Approach for Infected Necrotising Pancreatitis (Lancet, 2018)
- •ACG Guidelines: Management of Acute Pancreatitis — 2024 Update (Am J Gastroenterol, 2024)
Key Clinical Takeaways
The most important actionable points from this Practice Update on acute pancreatitis management. Each links to the detailed discussion below.
- 1Classify severity early using the Revised Atlanta Classification — mild, moderately severe, or severe — to guide where the patient should be managed and how aggressively to intervene → Predicting Severity
- 2Use goal-directed moderate fluid resuscitation with Ringer's lactate, not aggressive high-volume crystalloid — the WATERFALL trial showed aggressive fluids increase harm without improving outcomes → Early Resuscitation
- 3Start oral feeding as soon as the patient can tolerate it — there is no need to wait for pain to resolve or lipase to normalise → Nutrition
- 4Do not give prophylactic antibiotics for acute pancreatitis — they do not prevent infected necrosis and increase the risk of fungal superinfection → The Role of Antibiotics
- 5Perform urgent ERCP only when there is concurrent cholangitis or proven biliary obstruction — not for gallstone pancreatitis alone → When Is ERCP Needed?
- 6Perform cholecystectomy during the same admission for mild gallstone pancreatitis — delaying to an interval procedure exposes the patient to a high risk of recurrence → Preventing Recurrence
- 7Delay intervention for pancreatic necrosis until at least 4 weeks after onset to allow the collection to become walled-off — then use a step-up approach starting with drainage, not surgery → Managing Necrotising Disease
- 8Avoid routine early CT scanning — necrosis is not reliably identified before 72–96 hours, and imaging findings rarely change management in the first few days → Role of Imaging
- 9Manage pain aggressively using multimodal analgesia — uncontrolled pain drives a systemic inflammatory response and delays recovery → Early Resuscitation
- 10Always establish the aetiology — gallstones and alcohol account for roughly 80% of cases, but missing a rarer cause (hypertriglyceridaemia, autoimmune, tumour) changes the entire management plan → Establishing the Cause
How Should You Confirm the Diagnosis and Identify the Cause?
Acute pancreatitis requires two of three criteria: characteristic abdominal pain (acute onset, epigastric, often radiating to the back), serum lipase or amylase at least three times the upper limit of normal, and characteristic findings on cross-sectional imaging. In most cases the diagnosis is made on clinical and biochemical grounds alone — imaging is not needed to confirm the diagnosis if the first two criteria are met.
Establish the aetiology on admission in every patient. Obtain a detailed alcohol history, perform a right upper quadrant ultrasound to look for gallstones, measure triglycerides and calcium, and review the medication list. The cause should be identified in at least 80% of cases. Label a case as idiopathic only after a thorough workup.
Strong Rec Moderate Evidence IAP/APA 2013 ACG 2013Do not obtain a CT scan at admission to confirm the diagnosis if clinical and biochemical criteria are already met. Early CT cannot reliably identify necrosis (which takes 72–96 hours to demarcate) and rarely changes initial management. Reserve CT for patients who do not improve after 48–72 hours, who deteriorate clinically, or where the diagnosis is in doubt.
Strong Rec Moderate Evidence IAP/APA 2013 ACG 2013How Should You Predict Severity?
The Revised Atlanta Classification divides acute pancreatitis into mild (no organ failure, no local complications), moderately severe (transient organ failure resolving within 48 hours, or local complications without persistent organ failure), and severe (persistent organ failure lasting beyond 48 hours). Early identification of patients at risk for severe disease is critical because they need ICU-level care, aggressive monitoring, and a different management trajectory.
Assess for organ failure using the Modified Marshall Scoring System at admission and at 48 hours. Organ failure that persists beyond 48 hours defines severe acute pancreatitis and is the strongest predictor of mortality. The three organ systems assessed are respiratory (PaO2/FiO2), renal (creatinine), and cardiovascular (systolic blood pressure and response to fluids).
Strong Rec High Evidence Revised Atlanta 2013 IAP/APA 2013Use simple bedside markers to identify patients at risk of deterioration in the first 24 hours: SIRS criteria (two or more of: temperature >38 or <36 °C, heart rate >90, respiratory rate >20, WBC >12,000 or <4,000 or >10% immature bands), elevated BUN or creatinine, and haemoconcentration (haematocrit >44%). Persistent SIRS at 48 hours is a reliable early predictor of severe disease.
Strong Rec Moderate Evidence ACG 2013Acute Pancreatitis Severity: What Each Category Means for Your Management Plan
| Severity | Defining Feature | Where to Manage | Expected Course | Common Pitfalls |
|---|---|---|---|---|
| Mild | No organ failure, no local complications | Acute surgical or medical ward | Self-limiting; resolves within a week; mortality <1% | Ordering unnecessary CT scans; keeping patients nil by mouth for days; delaying cholecystectomy for gallstone aetiology |
| Moderately Severe | Transient organ failure (<48 h) or local complications (acute peripancreatic fluid collection, acute necrotic collection) | Close monitoring; HDU or step-down if organ support needed; consider ICU if borderline | May need prolonged hospitalisation; local complications may require later intervention; mortality ~5% | Intervening too early on local collections before they have matured; starting prophylactic antibiotics |
| Severe | Persistent organ failure (>48 h) — single or multi-organ | ICU; ideally in a centre with hepatobiliary/pancreatic expertise and interventional endoscopy | Prolonged ICU stay; high risk of infected necrosis; mortality 15–30% (higher with multi-organ failure) | Early open necrosectomy (now obsolete); failure to transfer to a specialist centre; delayed recognition of infected necrosis |
How Should You Resuscitate in the First 24 Hours?
Fluid resuscitation is the cornerstone of early acute pancreatitis management. For years, aggressive high-volume crystalloid was the standard. The WATERFALL trial has changed this — showing that aggressive fluids (20 mL/kg bolus then 3 mL/kg/h) were associated with more fluid overload and did not reduce moderately severe or severe disease compared with moderate resuscitation.
Resuscitate with Ringer's lactate at a moderate rate of 1.5 mL/kg/h, with reassessment and adjustment based on clinical targets (urine output 0.5–1 mL/kg/h, heart rate, mean arterial pressure, and haematocrit trend). Avoid aggressive high-volume resuscitation (20 mL/kg bolus + 3 mL/kg/h) as this increases fluid overload complications without improving outcomes.
Strong Rec High Evidence WATERFALL 2022 IAP/APA 2013Prefer Ringer's lactate over normal saline for fluid resuscitation. A small randomised trial and physiological rationale support its use: Ringer's lactate has a lower chloride load, may reduce SIRS, and does not exacerbate the metabolic acidosis that can accompany severe pancreatitis.
Moderate Rec Low Evidence ACG 2013Manage pain aggressively using multimodal analgesia. Paracetamol should be the base. Opioids (typically morphine or hydromorphone) remain appropriate for severe pain — the historical concern about morphine causing sphincter of Oddi spasm is not supported by clinical evidence. NSAIDs (indomethacin suppository) may be used as adjuncts if there are no contraindications.
Strong Rec Moderate Evidence IAP/APA 2013When and How Should You Feed the Patient?
Start oral feeding with a low-fat solid diet as soon as the patient can tolerate it — typically within 24 hours for mild cases, once abdominal pain is decreasing and inflammatory markers are improving. There is no need to wait for pain to resolve completely, for bowel sounds to return, or for lipase to normalise. Prolonged fasting is harmful: it promotes gut mucosal atrophy, bacterial translocation, and delays recovery.
Strong Rec High Evidence IAP/APA 2013 ACG 2013Use enteral nutrition (via nasogastric or nasojejunal tube) for patients with severe pancreatitis who cannot tolerate oral feeding. Enteral nutrition is superior to parenteral nutrition: it preserves gut barrier integrity, reduces infectious complications, and lowers mortality. Nasogastric feeding is as safe as nasojejunal and easier to place.
Strong Rec High Evidence IAP/APA 2013Should You Give Prophylactic Antibiotics?
Do not administer prophylactic antibiotics in acute pancreatitis, even in severe or necrotising disease. Multiple randomised trials and meta-analyses have failed to demonstrate that prophylactic antibiotics reduce infected necrosis, organ failure, or mortality. They do increase the risk of fungal infection and antibiotic resistance.
Against High Evidence IAP/APA 2013 ACG 2013Start therapeutic antibiotics when infected necrosis is suspected (clinical deterioration after initial improvement, gas in a necrotic collection on CT, or positive fine-needle aspirate). Use agents with good pancreatic tissue penetration: carbapenems, fluoroquinolones plus metronidazole, or third-generation cephalosporins plus metronidazole.
Strong Rec Moderate Evidence IAP/APA 2013When Is ERCP Needed in Acute Pancreatitis?
Perform urgent ERCP (within 24 hours) in patients with acute gallstone pancreatitis who have concurrent acute cholangitis. Cholangitis is the indication — not pancreatitis per se. Signs of cholangitis include fever, jaundice, and a dilated common bile duct with evidence of obstruction.
Strong Rec High Evidence IAP/APA 2013 ACG 2013Do not perform routine early ERCP in gallstone pancreatitis without cholangitis or proven persistent biliary obstruction. Randomised trials have shown no benefit of early ERCP for gallstone pancreatitis alone, and the procedure carries its own risks of worsening pancreatitis, bleeding, and perforation.
Against High Evidence IAP/APA 2013How Do You Prevent Recurrent Gallstone Pancreatitis?
Perform cholecystectomy during the same admission for patients with mild gallstone pancreatitis. The PONCHO trial demonstrated that same-admission cholecystectomy reduced the composite endpoint of readmission for gallstone-related complications (recurrent pancreatitis, cholecystitis, biliary colic) by roughly 70% compared with interval cholecystectomy at 25–30 days.
Strong Rec High Evidence PONCHO 2015 IAP/APA 2013Defer cholecystectomy for 6 weeks or more in patients with severe or necrotising gallstone pancreatitis to allow local inflammation to resolve. In patients with peripancreatic collections or necrosis, early cholecystectomy carries a higher risk of complications. ERCP with sphincterotomy during the acute admission provides temporary protection against recurrence while awaiting delayed surgery.
Strong Rec Moderate Evidence IAP/APA 2013How Should You Manage Pancreatic Necrosis?
Necrotising pancreatitis occurs in roughly 20% of patients and carries the highest morbidity and mortality. The paradigm has shifted dramatically over the past two decades: early open necrosectomy has been replaced by a step-up approach that starts with drainage and escalates to surgery only when needed — and only after the collection has matured into a walled-off necrosis.
Delay intervention for (peri)pancreatic necrosis until at least 4 weeks after disease onset whenever possible, to allow the collection to mature into a walled-off necrosis (WON). Early intervention on immature collections is technically more difficult, has higher complication rates, and worse outcomes.
Strong Rec High Evidence IAP/APA 2013 Dutch Step-Up 2010Use a step-up approach for infected necrotising pancreatitis: start with percutaneous catheter drainage (or endoscopic transluminal drainage where available). If drainage alone fails to control sepsis, escalate to minimally invasive necrosectomy (video-assisted retroperitoneal debridement or endoscopic necrosectomy). Open necrosectomy is a last resort.
Strong Rec High Evidence Dutch Step-Up 2010 IAP/APA 2013Do not perform early open necrosectomy. The Dutch Pancreatitis Study Group's landmark trial demonstrated that the step-up approach reduced the composite endpoint of major complications or death from 69% to 40%, and new-onset multi-organ failure from 40% to 12%, compared with primary open necrosectomy, with lower mortality and fewer long-term complications including exocrine and endocrine insufficiency.
Against High Evidence Dutch Step-Up 2010The Step-Up Approach to Infected Necrosis: When to Escalate
| Step | Intervention | When to Use | Success Rate | Practical Tip |
|---|---|---|---|---|
| Step 1 | Antibiotics alone (if infection suspected but patient is stable) | Clinical suspicion of infected necrosis without septic shock; gas on CT may be present | Some patients stabilise with antibiotics alone and never require drainage | Choose carbapenems or fluoroquinolone + metronidazole for pancreatic tissue penetration. Reassess daily. |
| Step 2 | Percutaneous catheter drainage (or endoscopic transluminal drainage) | Failure to improve on antibiotics; worsening sepsis; ideally after 4 weeks (WON formed) | Resolves infection in approximately 35–50% of patients without need for further escalation | Place large-bore drains (14–16 Fr minimum). May need multiple drains or upsizing. Endoscopic approach preferred where expertise exists. |
| Step 3 | Minimally invasive necrosectomy (VARD, endoscopic necrosectomy, or sinus tract endoscopy) | Failure of drainage to control infection; significant solid necrotic debris preventing drain resolution | Resolves the majority of remaining cases | VARD uses the percutaneous drain tract as the access route. Endoscopic necrosectomy is performed through a transgastric stent. Both are far better tolerated than open surgery. |
| Step 4 (last resort) | Open necrosectomy | Failure of all minimally invasive approaches; rare | Effective but carries significant morbidity | Should only be performed in specialist hepatobiliary/pancreatic centres. Consider transfer if your institution does not have this expertise. |
Clinical Decision Pathway
Evidence in Context
Where IAP/APA and ACG Agree
Both frameworks agree on the Revised Atlanta Classification for severity, early goal-directed fluid resuscitation (though WATERFALL has since refined the volume), early oral feeding, avoidance of prophylactic antibiotics, the restricted role of ERCP (only with cholangitis), same-admission cholecystectomy for mild gallstone pancreatitis, and the step-up approach for infected necrosis with delayed intervention.
The WATERFALL Trial: Redefining Fluid Resuscitation
The WATERFALL trial randomised 249 patients across 18 centres to aggressive (20 mL/kg bolus then 3 mL/kg/h) versus moderate (1.5 mL/kg/h with bolus only if hypovolaemic) Ringer's lactate resuscitation. The trial was stopped early because aggressive fluids caused more fluid overload (20% vs 6%) without reducing moderately severe or severe pancreatitis. This trial overturned the longstanding practice of "flooding" pancreatitis patients and established moderate, goal-directed resuscitation as the standard.
The Dutch Step-Up Trials: How They Changed Necrosectomy
The Dutch Pancreatitis Study Group's PANTER trial (2010) demonstrated that a step-up approach — starting with percutaneous drainage and escalating to minimally invasive necrosectomy only when needed — reduced the composite endpoint of major complications or death from 69% to 40%, with new-onset multi-organ failure falling from 40% to 12% compared with primary open necrosectomy. The subsequent TENSION trial (2018) further showed that endoscopic transluminal drainage and necrosectomy was superior to the surgical step-up approach for certain collection locations. Together, these trials established that the vast majority of infected necrosis can be managed without open surgery.
What We Still Don't Know
References
- 1.Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1–e15. doi:10.1016/j.pan.2013.07.063
- 2.Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology Guideline: Management of Acute Pancreatitis. Am J Gastroenterol. 2013;108(9):1400–1415. doi:10.1038/ajg.2013.218
- 3.Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi:10.1136/gutjnl-2012-302779
- 4.da Costa DW, Bouwense SA, Schepers NJ, et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. Lancet. 2015;386(10000):1261–1268. doi:10.1016/S0140-6736(15)00274-3
- 5.de-Madaria E, Buxbaum JL, Maisonneuve P, et al. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis. N Engl J Med. 2022;387(11):989–1000. doi:10.1056/NEJMoa2202884
- 6.van Santvoort HC, Besselink MG, Bakker OJ, et al. A Step-Up Approach or Open Necrosectomy for Necrotizing Pancreatitis. N Engl J Med. 2010;362(16):1491–1502. doi:10.1056/NEJMoa0908821
- 7.van Brunschot S, van Grinsven J, van Santvoort HC, et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial. Lancet. 2018;391(10115):51–58. doi:10.1016/S0140-6736(17)32404-2
- 8.Tenner S, Vege SS, Sheth SG, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. Am J Gastroenterol. 2024;119(3):419–437. doi:10.14309/ajg.0000000000002645
How to Read the Evidence Tags
Every recommendation carries two tags indicating recommendation strength and evidence quality. These are Medaptly's own simplified interpretations for educational clarity.
Recommendation Strength
| Tag | What It Means | In Practice |
|---|---|---|
| Strong Rec | High-quality evidence broadly supports this action. Benefits clearly outweigh risks. | Standard practice for most patients. |
| Moderate Rec | Evidence favours this action, though some uncertainty remains. | Most patients should receive this, but context may lead to a different decision. |
| Conditional Rec | Benefit less certain. Depends on patient circumstances. | Use shared decision-making. |
| Against | Evidence shows no benefit, or risks outweigh benefits. | Avoid. Document reasoning if used exceptionally. |
Evidence Quality
| Tag | What It Means | Confidence Level |
|---|---|---|
| High Evidence | Multiple RCTs or high-quality meta-analyses. | Very confident. |
| Moderate Evidence | Single RCT or large observational studies. | Reasonably confident. |
| Low Evidence | Expert consensus or extrapolated evidence. | Less certain. May change. |
These are Medaptly's simplified interpretations. For the full classification systems, consult the original documents in References.